Cartesian Therapeutics, Inc. (RNAC)
6.83
+0.97
(+16.55%)
USD |
NASDAQ |
Jun 09, 16:00
6.72
-0.11
(-1.61%)
After-Hours: 16:33
Cartesian Therapeutics Profit Margin (Quarterly) : -50.23K% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| C4 Therapeutics, Inc. | -408.5% |
| Arrowhead Pharmaceuticals, Inc. | -186.6% |
| Oncolytics Biotech, Inc. | -- |
| Sangamo Therapeutics, Inc. | -2.15K% |
| Sarepta Therapeutics, Inc. | 45.29% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -43.23% |
| Gross Profit Margin (Quarterly) | -688.5% |
| Operating Margin (Quarterly) | -33.97K% |
| Return on Net Operating Assets | -78.25% |